释义 |
DictionarySeehypersensitivityimmune complex disease
Immune complex disease Local or systemic tissue injury caused by the vascular deposition of products of antigen-antibody interaction, termed immune complexes. Immune complex formation with specific antibodies causes the inactivation or elimination of potentially harmful consequences only when immune complexes deposit in tissues, inciting various mediators of inflammation. When the reaction takes place in the extravascular fluids near the site of origin of the antigen (by injection, secretion, and such), focal injury can occur, as exemplified by the Arthus reaction or such conditions as experimental immune thyroiditis. Systemic disease may occur when soluble antigens combine with antibodies in the vascular compartment, forming circulating immune complexes that are trapped nonspecifically in the vascular beds of various organs, causing such clinical diseases as serum sickness or systemic lupus erythematosus with vasculitis and glomerulonephritis. The term immune complex disease usually signifies this systemic immune complex formation and vascular deposition. See Antigen-antibody reaction Circulating immune complex disease occurs when the host's antibody production, relative to the amount of antigens, is inadequate for prompt elimination of antigen. Normally, excess amounts of antibody are formed which generate large immune complexes that are removed very rapidly from the circulation and are disposed of by the mononuclear phagocytic system. If the antibody response is very poor, only a few very small complexes are formed which are not prone to vascular deposition. When the relative antibody production is such that complexes of intermediate size form, vascular trapping can occur and injury results from the effects of inflammation. In addition to immune complex size, other factors influence vessel deposition, including the efficiency of systemic clearance of immune complexes, the hemodynamics of blood flow, and vasoactive amine-influenced changes in vascular permeability. Through dynamic equilibrium, continual modification of the deposits occurs as antigen and antibody fluctuate in the body fluids. Treatment of immune complex disease can be divided into nonspecific and more specific modalities. Primary among the specific measures is the identification and elimination of the offending antigen. This may be possible with some infections when specific therapies are available, and in certain instances where the antigenic source can be removed, such as a neoplasm. More frequently, nonspecific anti-inflammatory (corticosteroids) and immunosuppressive agents (such as cyclophosphamide and azathioprine) are used to attempt to blunt the person's immune response, thereby lessening the amount of immune complexes produced. See Autoimmunity, Immunology immune complex disease[i¦myün ¦käm‚pleks di‚zēz] (medicine) A disease that results from deposition of antigen-antibody complexes in tissues. immune complex disease
immune [ĭ-mūn´] 1. being highly resistant to a disease because of the formation of humoral antibodies or the development of immunologically competent cells, or both, or as a result of some other mechanism, as interferon activities in viral infections.2. characterized by the development of humoral antibodies or cellular immunity, or both, following antigenic challenge" >challenge.3. produced in response to antigenic challenge, as immune serum globulin.immune response the reaction to and interaction with substances interpreted by the body as not-self" >not-self, the result being humoral and cellular immunity. Called also immune reaction. The immune response depends on a functioning thymus and the conversion of stem cells to B and lymphocytes" >T lymphocytes. These lymphocytes contribute to antibody production, cellular immunity, and immunologic memory.Disorders of the Immune Response. Pathologic conditions associated with an abnormal immune response (immunopathy) may result from (1) immunodepression, that is, an absent or deficient supply of the components of either humoral or cellular immunity, or both; (2) excessive production of gamma globulins; (3) overreaction to antigens of extrinsic origin, that is, antigens from outside the body; and (4) abnormal response of the body to its own cells and tissues. Those conditions arising from immunosuppression include agammaglobulinemia (absence of gamma globulins) and hypogammaglobulinemia (a decrease of circulating antibodies). Factors that may cause or contribute to suppression of the immune response include (1) congenital absence of the thymus or of the stem cells that are precursors of B and T lymphocytes; (2) malnutrition, in which there is a deficiency of the specific nutrients essential to the life of antibody-synthesizing cells; (3) cancer, viral infections, and extensive burns, all of which overburden the immune response mechanisms and rapidly deplete the supply of antigen-specific antibody; (4) certain drugs, including alcohol and heroin, some antibiotics, antipsychotics, and the antineoplastics used in the treatment of cancer. Overproduction of gamma globulins" >gamma globulins is manifested by an excessive proliferation of plasma cells (multiple myeloma). hypersensitivity is the result of an overreaction to substances entering the body. Examples of this kind of inappropriate immune response include hay fever, drug and food allergies, extrinsic asthma, serum sickness" >serum sickness, and anaphylaxis. Autoimmune diseases are manifestations of the body's abnormal response to and inability to tolerate its own cells and tissues. For reasons not yet fully understood, the body fails to interpret its own cells as self and, as it would with other foreign (not-self) substances, utilizes antibodies and immunologically competent cells to destroy and contain them.immune system a complex system of cellular and molecular components whose primary function is distinguishing self from nonself and defense against foreign organisms or substances; see also immune response. The primary cellular components are lymphocytes and macrophages, and the primary molecular components are antibodies and lymphokines; granulocytes and the complement system are also involved in immune responses but are not always considered part of the immune system per se. Major organs and tissues of the immune system in the child. From McKinney et al., 2000.immune complex disease local or systemic disease caused by the formation of circulating antibody-antigen immune complexes and their deposition in tissue, due to activation of complement and to recruitment and activation of leukocytes in type III hypersensitivity reactions.im·mune com·plex dis·easean immunologic category of diseases evoked by the deposition of antigen-antibody in the microvasculature. Complement is frequently involved and the breakdown products of complement attract polymorphonuclear leukocytes to the site of deposition. Damage to tissue is frequently caused by "frustrated" phagocytosis by polymorphonuclear cells. Vasculitis or nephritis is common. Other clinical manifestations include fever, arthralgias, and cutaneous eruptions. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue diseases, may belong in this immunologic category. Immune complex diseases can also occur during a variety of diseases of known etiology, such as subacute bacterial endocarditis. See also: autoimmune disease, immune complex. Synonym(s): immune complex disorder, type III hypersensitivity reactionimmune complex disease Immunology Any of a number of conditions—caused by circulating antigen-antibody-immune complexes, which in the face of mild antigen excess, lodge in small vessels and filtering organs of the circulation Clinical Fever, enlarged and/or tender joints, splenic congestion, proteinuria due to glomerular IC deposition, eosinophilia, hypocomplementemia, lymphadenopathy, glomerulonephritis–HTN, oliguria, hematuria, edema, skin–purpura, urticaria, ulcers, carditis, hepatitis, myositis, necrotizing vasculitis. See Immune complex. Immune complex disease Arthus reaction Acute hemorrhagic necrosis that follows re-exposure to an antigen, which attracts PMNs, activates complement, binds ICs by the Fc receptor, causing phagocytosis, ↑ production of chemotactic factors, especially C5b67 and ↑ anaphylotoxins C3a and C5a, resulting in vasodilation Serum sickness A reaction that is milder than the Arthus reaction, occurring 8-12 days after exposure to the antigen, at the time of 'equivalence' (antigen and antibody are in a 1:1 ratio), after injection of a foreign protein mixture, eg horse serum for antitoxin to tetanus im·mune com·plex dis·ease (i-myūn' kom'pleks di-zēz') Immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent development of vasculitis; nephritis is common. Most of the connective tissue diseases may belong in this immunologic category; immune complex diseases can also occur during a variety of diseases of known etiology, such as subacute bacterial endocarditis. See also: autoimmune diseaseim·mune com·plex dis·ease (i-myūn' kom'pleks di-zēz') Immunologic category of diseases evoked by the deposition of antigen-antibody in the microvasculature. Complement is frequently involved and the breakdown products of complement attract polymorphonuclear leukocytes to site of deposition. Damage to tissue is frequently caused by "frustrated" phagocytosis by polymorphonuclear cells. Immune complex diseases can also occur during a variety of diseases of known etiology, such as subacute bacterial endocarditis. See also: autoimmune disease |